This document is a publication of a patent application (EP3962925A1) by the European Patent Office (EPO) on March 11, 2026. The application, titled "Halogenated Antimicrobial Peptoids," lists Maxwell Biosciences, Inc. as the applicant and identifies specific inventors. The publication details International Patent Classification (IPC) codes related to peptides, antimicrobial agents, and pharmaceutical preparations.

As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on entities. However, it signifies potential future developments in antimicrobial technology, which may be relevant for pharmaceutical companies and drug manufacturers in terms of intellectual property and market landscape. Compliance officers should note this publication as a marker of innovation in the peptide-based antimicrobial space.